NCT04178733View on ClinicalTrials.gov

A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

May 11, 2020

Study Completion Date

May 11, 2020

Conditions
Healthy
Interventions
DRUG

LY3493269 - SC

Administered SC

DRUG

Placebo - SC

Administered SC

DRUG

LY3493269 - IV

Administered IV

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04178733 - A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants | Biotech Hunter | Biotech Hunter